Bunge Global SA (BG)
Bunge processes oilseeds and grains and produces edible oils and agricultural commodities worldwide.
BG vs KR: how the two businesses compare
- Bigger business: KR, with $147.6B of yearly revenue, about 2.1× BG's $70.3B.
- More cash from each sale: KR turns 5 cents of each sales dollar into operating cash flow, against 1 cents at BG.
From each company's latest annual SEC filing. Fiscal years can end on different dates.
Kroger (KR) is the larger business by reported revenue: $147.6B in its fiscal year ended Jan 2026, about 2.1× BG's $70.3B (fiscal year ended Dec 2025). BG's net margin was 1.2% and KR's 0.7%. The SEC classifies them differently (Fats & Oils; Retail-Grocery Stores); what connects them is shared exposure to the Economic trends research theme, not a common industry.
Figures come from each company's own SEC filings. This page compares the businesses; it is not a price target or a verdict.
- Consumer Staples
- Different
- Separate classifications
- Different
- BG December 31 · KR January 30
- Mar 31, 2026
BG vs KR: quick comparison
| Company fact | BG | KR |
|---|---|---|
| Company | Bunge Global SA | The Kroger Co. |
| Exchange | NYSE | NYSE |
| SEC industry | Fats & Oils | Retail-Grocery Stores |
| Fiscal year-end | December 31 | January 30 |
| Latest annual filing | 10-K · 2026-02-19 | 10-K · 2026-03-31 |
BG vs KR: audited financials
- Scale: KR's $147.6B of revenue is about 2.1× BG's $70.3B.
- Net margin: nearly identical at 1.2% (BG) and 0.7% (KR).
- Cash conversion: operating cash flow equalled BG 1.2% of revenue, or 1.03× net income; KR 5.0% of revenue, or 7.20× net income. A ratio well above 1× usually reflects non-cash charges or working-capital release; well below 1× can reflect working-capital build or non-cash gains.
- Periods: the fiscal years end about 1 month apart (2025-12-31 for BG, 2026-01-31 for KR), so each figure reflects somewhat different demand and cost conditions.
| Metric | BG | KR |
|---|---|---|
| Revenue | $70.3B2025-01-01 to 2025-12-31 · SEC filing | $147.6B2025-02-02 to 2026-01-31 · SEC filing |
| Net income | $816M2025-01-01 to 2025-12-31 · SEC filing | $1.0B2025-02-02 to 2026-01-31 · SEC filing |
| Operating cash flow | $844M2025-01-01 to 2025-12-31 · SEC filing | $7.3B2025-02-02 to 2026-01-31 · SEC filing |
| Diluted EPS | $4.912025-01-01 to 2025-12-31 · SEC filing | $1.542025-02-02 to 2026-01-31 · SEC filing |
| Net margin | 1.2%2025-01-01 to 2025-12-31 · SEC filing | 0.7%2025-02-02 to 2026-01-31 · SEC filing |
BG: FY ending 2025-12-31 · KR: FY ending 2026-01-31. Figures as tagged in each issuer's SEC XBRL filing; fiscal calendars may not align.
Where BG and KR overlap, and where they don't
Overlap
- Shared research theme: Economic trends.
Differences
- Different SEC industries: BG files as Fats & Oils; KR as Retail-Grocery Stores.
- Offset fiscal calendars: BG's year ends December 31 and KR's January 30, about 1 month apart.
- Only BG maps to Tariffs & trade.
- Scale: KR reported about 2.1× the annual revenue of BG.
Overlap is drawn from SEC classifications and Yield Theory research themes. It is not evidence that the companies sell to the same customers or compete product for product.
The Kroger Co. (KR)
Kroger operates one of the largest US supermarket chains along with pharmacies and private-label brands.
What moves each company
Company-specific drivers maintained by Yield Theory. Use them to decide which filing deserves deeper work; they are not predictions.
What moves BG
We have not yet published a company-specific driver list for BG. The primary source is Item 1 (Business) and Item 1A (Risk Factors) of its 10-K filed 2026-02-19.
What moves KR
We have not yet published a company-specific driver list for KR. The primary source is Item 1 (Business) and Item 1A (Risk Factors) of its 10-K filed 2026-03-31.
The investment question
You now know KR reports about 2.1× BG's revenue, and BG keeps more of each dollar as net income. Those are the facts. The investment question is what each share price already assumes about their exposure to economic trends, and which evidence in the next filings would prove that assumption wrong.
Members-only research
What members are reading this month
- Issue 07: The Vote That Knocked Almost a Quarter off Data Center Stocks
Texas has frozen new data center approvals since the summer. The vote extends that freeze, but it cannot unplug campuses that already have power. We map who is exposed, test whether the sell-off overshot and say where the real risk sits.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchSEC filing comparison and disclosure evidence
Start with primary filings because fiscal calendars and accounting presentation can make superficially similar quarters incomparable. BG's fiscal year ends December 31, while KR's ends January 30. Normalize the reporting periods before comparing growth, margins, capital intensity, or guidance.
The current verified House and Senate snapshot contains 1 matched transaction row for BG and 18 matched transaction rows for KR. These delayed, range-based disclosures can identify a filing to inspect; they do not establish motive, conviction, or a real-time trading signal.
BG primary filings
KR primary filings
What this comparison cannot tell you
This page does not contain licensed live prices, a valuation model, earnings estimates, portfolio constraints, or a forecast of future returns. SEC classifications can be broad, company descriptions can lag strategic change, and the latest annual filing may predate a material acquisition or divestiture. Read subsequent quarterly and current reports before making a decision.
A stronger business is not automatically the better stock. Starting valuation, expectations, capital structure, cyclicality, dilution, and the probability of each thesis determine the investment outcome. Use this comparison to frame the work, then verify the numbers in the linked filings and current company disclosures.
BG vs KR FAQs
Are BG and KR direct competitors?
Not necessarily. Bunge Global SA files as Fats & Oils and Kroger as Retail-Grocery Stores. The pair is compared because both map to the Economic trends research theme, not because the filings show head-to-head competition.
Is BG or KR the bigger company by revenue?
Kroger (KR) is the larger business by reported revenue: $147.6B in its fiscal year ended Jan 2026, about 2.1× BG's $70.3B (fiscal year ended Dec 2025). BG's net margin was 1.2% and KR's 0.7%. The SEC classifies them differently (Fats & Oils; Retail-Grocery Stores); what connects them is shared exposure to the Economic trends research theme, not a common industry. Each figure is the annual amount tagged in the company's own SEC XBRL filing; market value depends on live prices, which this page does not publish.
Which is better, BG or KR?
There is no context-free winner. Compare the operating exposures, filing evidence, valuation, balance sheet, and risks against the specific thesis you are testing. This page deliberately does not turn a static profile into a buy or sell recommendation.
Does this BG vs KR comparison include live prices?
No. Yield Theory does not republish unlicensed real-time market data. The financial figures on this page are the audited annual numbers Bunge Global SA and The Kroger Co. tagged in their SEC XBRL filings. Use a regulated broker or licensed quote provider for current prices and valuation multiples.
Where does the company information come from?
Company classifications, fiscal year-ends, and filing links come from the SEC EDGAR submissions API snapshot refreshed 2026-11-09. Business summaries and research themes are maintained by Yield Theory.
Data snapshot: SEC EDGAR submissions API, refreshed 2026-11-09. Independent educational research; not investment advice.
Which business differences matter to the investment thesis?
BG vs KR compares reported results. The reports below show how we connect operating evidence to an investment thesis, its assumptions, catalysts, and risks. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included